Search

everythinglearnresearchcommunity

for

Search:↓

The research found that a protein called caveolin-1 is reduced in psoriasis, but reintroducing it can help alleviate some psoriasis symptoms.

A 25-year-old man with multiple skin tumors was successfully treated with acitretin and methotrexate.

Baricitinib is a safe and effective alternative for alopecia areata patients who do not respond to tofacitinib.

A rare lupus case on the chin was successfully treated with steroids and immunomodulators after accurate diagnosis using advanced imaging techniques.

Combining cytostatic and steroid drugs effectively treats systemic lupus erythematosus.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

A man's hair regrew from alopecia areata after using tofacitinib and experiencing contact dermatitis from a wig device.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

New therapies are being developed that target integrin pathways to treat various diseases.

Nilotinib can cause keratosis pilaris, a skin condition.

Early treatment with the right dose of stem cells can reduce lupus symptoms.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Baricitinib helped regrow hair in patients with severe alopecia areata after other treatments failed.

Ritlecitinib successfully treated a child's alopecia universalis after baricitinib failed.

Metreleptin treatment significantly improved metabolic health in a boy with congenital generalized lipodystrophy.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

Treating Netherton syndrome with growth hormone and dupilumab improves growth safely.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

IL-26 has antimicrobial and pro-inflammatory effects in the chronic skin condition Hidradenitis Suppurativa.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

Upadacitinib improves life quality for Alopecia Areata patients without worsening skin issues.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Ustekinumab might work for severe psoriasis, but more research is needed to be sure.

Dupilumab and ustekinumab are promising treatments for alopecia areata, showing significant hair regrowth.

Tofacitinib can help hair grow back in alopecia patients but hair loss might return if the dose is lowered.

The document did not conclude on apremilast's effectiveness for severe alopecia areata.

Thymoma-associated multiorgan autoimmunity can cause liver damage and affects multiple organs, with limited treatment options and a generally poor prognosis.

Dupilumab may help regrow hair in people with atopic dermatitis.